Related Experiment Video

Updated: Jul 25, 2026

Humanized Mouse Model to Study Bacterial Infections Targeting the Microvasculature
11:40

Humanized Mouse Model to Study Bacterial Infections Targeting the Microvasculature

Published on: April 1, 2014

Recognition, treatment and complications of meningococcal disease

F A Riordan1, A P Thomson

  • 1Birmingham Heartlands and Solihull NHS Trust (Teaching), England.

Paediatric Drugs
|August 10, 2000
PubMed

Insights

Early recognition of severe meningococcal disease, particularly meningococcal septicaemia with its characteristic purpuric rash, is crucial. Prompt diagnosis and treatment by parents and physicians can significantly decrease mortality in young children.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Meningococcal disease is a significant cause of mortality in young children.
  • Life-threatening cases often present as meningococcal septicaemia, characterized by a purpuric rash, rather than meningitis.

Purpose of the Study:

  • To emphasize the importance of early recognition and prompt treatment in reducing mortality from meningococcal disease.
  • To highlight the role of parents, primary care physicians, and hospital doctors in timely intervention.

Main Methods:

  • Review of clinical presentation and management strategies for meningococcal disease.
  • Discussion of diagnostic tools like the Glasgow Meningococcal Septicaemia Prognostic Score (GMSPS) for severity assessment.
  • Evaluation of current treatment protocols and the need for evidence-based new therapies.

Main Results:

  • The purpuric rash is a key indicator for seeking medical advice and initiating prompt penicillin treatment.
  • Delayed or absent antibacterial therapy occurs in atypical presentations or without a rash.
  • The Glasgow Meningococcal Septicaemia Prognostic Score aids in identifying high-risk patients needing intensive care.

Conclusions:

  • Early recognition of severe meningococcal disease by all healthcare levels is paramount for decreasing mortality.
  • While new treatments are explored, timely diagnosis and intervention remain critical.
  • Effective management involves prompt parenteral penicillin for suspected cases with rash and appropriate hospital-based care, including severity assessment.

More Related Videos

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection05:55

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Published on: May 7, 2020

Related Concept Videos

Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...